Enanta Pharmaceuticals (ENTA) Receivables - Other (2012 - 2015)

Enanta Pharmaceuticals (ENTA) has 4 years of Receivables - Other data on file, last reported at $1.0 million in Q4 2015.

• For the quarter ending Q4 2015, Receivables - Other fell 46.39% year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2015 stood at $1.0 million (down 46.39% YoY), and the FY2015 full-year result was $433000.0, down 84.37% from the prior year.
• Receivables - Other for Q4 2015 stood at $1.0 million, up from $433000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $2.8 million in Q3 2014 and bottomed at $433000.0 in Q3 2015.
• The 4-year median for Receivables - Other is $1.4 million (2015), against an average of $1.4 million.
• The widest annual swing landed in 2014, when Receivables - Other jumped 253.32%; it then tumbled 84.37% in 2015.
• A 4-year view of Receivables - Other shows it stood at $1.7 million in 2012, then sank by 44.3% to $929000.0 in 2013, then surged by 102.58% to $1.9 million in 2014, then tumbled by 46.39% to $1.0 million in 2015.
• The last three Receivables - Other figures came in at $1.0 million (Q4 2015), $433000.0 (Q3 2015), and $1.4 million (Q2 2015), per Business Quant data.

Peer Comparison